Novoa-Loyola Jose E. 4
4 · TRIPLE-S MANAGEMENT CORP · Filed Mar 8, 2018
Insider Transaction Report
Form 4
Novoa-Loyola Jose E.
Chief Medical Officer
Transactions
- Award
Class B Common Stock
2018-03-06+3,857→ 11,633 total - Award
Class B Common Stock
2018-03-06+1,026→ 12,659 total
Footnotes (2)
- [F1]Shares acquired represent grant of restricted stock that will vest in equal installments on each of March 6, 2019, 2020 and 2021.
- [F2]Shares acquired represent common stock earned pursuant to a grant of Performance Shares on August 17, 2015. The Performance Shares resulting in the issuance of these shares of common stock did not constitute derivative securities. As a result, such Performance Shares were not required to be reported and were not reported on a Form 4 at the time of the award.